Location History:
- Bethel, CT (US) (2017 - 2018)
- Seattle, WA (US) (2019 - 2020)
- Shoreline, WA (US) (2020 - 2022)
Company Filing History:
6 out of 2,103 
1 out of 1,536 
Years Active: 2017-2025
Title: Inventor Spotlight: Eric T Larson
Introduction
Eric T Larson is a prominent inventor based in Seattle, WA. With a remarkable portfolio of six patents, he has made significant contributions to the field of medical treatments, specifically in combating parasitic diseases.
Latest Patents
Eric's latest patents focus on innovative compositions and methods for treating toxoplasmosis and cryptosporidiosis, which are caused by infectious eukaryotic parasites. His work emphasizes inhibiting calcium-dependent protein kinases (TgCDPKs and CpCDPKs) using pyrazolopyrimidine and imidazo[1,5-a]pyrazine inhibitors. These patented methods have the potential to greatly enhance therapeutic approaches for diseases linked to apicomplexan protozoan.
Career Highlights
Throughout his career, Eric has worked with notable institutions such as the University of Washington and Boehringer Ingelheim International GmbH. His experience in these prestigious organizations has enriched his research and allowed him to push the boundaries of medical science.
Collaborations
Eric has collaborated with esteemed colleagues, including Wesley C Van Voorhis and Wilhelmus G J Hol. These partnerships have fostered a collaborative environment that drives innovation and enhances the quality of research outcomes.
Conclusion
With his ongoing research and numerous patents, Eric T Larson continues to be a significant figure in the fight against parasitic diseases. His contributions not only advance scientific understanding but also pave the way for new treatment options that could benefit countless individuals around the world.